Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
Lesley Anderson(Queen's University Belfast), M. Meyer(Universidad de Granada), Karri Seppä, Michael B. Cook(University of Oxford), Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Aurélien Belot, Guy Launoy(Inserm), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Gerda Engholm(National Board of Health and Welfare), Marc Maynadié(Universidad de Granada), Carmen Navarro(Universidad Autónoma de Madrid), Pascale Grosclaude(Seoul National University Children's Hospital), Florence Molinié, Bernd Holleczek(Krebsregister Saarland), Hans H. Storm(Danish Cancer Society), K. Henau, Anne‐Sophie Woronoff, Alain Monnereau, Michel Robaszkiewicz(Universidad de Granada), Nadine Bossard(Istituto Superiore di Sanità), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Véronique Bouvier(Inserm), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), Hermann Brenner(Universidad de Granada), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nea Malila(Istituto Superiore di Sanità), Miroslav Zvolský(Institute of Health Information and Statistics), Willi Oberaigner, Brian T. Johnston(Belfast Health and Social Care Trust), Anna Gavin(Queen's University Belfast), Andrea Tavilla, X. Troussard, B. Lapôtre‐Ledoux(Fondazione IRCCS Istituto Nazionale dei Tumori), Monika Hackl(Universidad de Granada), P. Arveux(Istituto Superiore di Sanità), S. Bara(Fondazione IRCCS Istituto Nazionale dei Tumori), Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), E. Van Eycken(Istituto Superiore di Sanità), Brigitte Trétarre(Queen's University Belfast), Finian Bannon(Queen's University Belfast), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Isabelle Baldi(Pancreatic Cancer Action Network), A.V. Guizard, N. Zielonke(Istituto Superiore di Sanità)
Cited by 177
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k